肺癌患者的生存率和并发症:来自德国行政索赔数据的证据
Diego Hernandez1, Chih-Yuan Cheng1,2, Karla Hernandez-Villafuerte1
1Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Oncology research
|June 12, 2023
概括
伴随性疾病在德国显著影响肺癌存活率. 诸如心力衰竭和脏疾病等疾病显著降低了存活率,凸显了综合患者护理的必要性.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 肺癌是全球和德国的主要死亡原因.
- 伴随性疾病对肺癌患者预后的影响仍在调查中.
- 了解这些并发症对于改善患者的治疗结果至关重要.
研究的目的:
- 调查德国肺癌患者的并发症的流行情况.
- 分析常见的并发症与肺癌患者存活率之间的关联.
- 为临床管理和公共卫生战略提供数据驱动的见解.
主要方法:
- 分析来自德国一家大型法定医疗保险基金的行政索赔数据 (大约. 9百万个人,2005年至2019年).
- 使用ICD-10-GM代码识别肺癌病例和并发症.
- 使用查尔森并发症指数 (CCI) 进行并发症的分类,并使用卡普兰-梅尔曲线进行生存分析.
主要成果:
- 确诊了70,698例肺癌病例;发病率和存活率与国家统计数据一致.
- 最常见的并发病:COPD (36.7%),PVD (18.7%),糖尿病 (17.4%),CHF (16.5%),以及脏疾病 (14.7%).
- 充血性心力衰竭,脑血管疾病和脏疾病对存活率产生了最大的负面影响 (≥9%的下降),而PVD和糖尿病对存活率产生了中等影响 (≤7%的下降).
结论:
- 在德国,常见的并发症和肺癌患者的存活率之间存在显著的负相关性.
- 特定的并发症,如心脏不全症,CEVD和病,大大降低了生存概率.
- 需要进一步的研究来分离并发症与其他患者因素的独立影响.
相关概念视频
01:21Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
01:20Comparing the Survival Analysis of Two or More Groups
228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
01:25Statistical Methods for Analyzing Epidemiological Data
427
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
427
01:24Kaplan-Meier Approach
195
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
195
01:15Assumptions of Survival Analysis
160
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
160
01:20Actuarial Approach
101
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
101